Page last updated: 2024-08-17

bromodeoxyuridine and azaserine

bromodeoxyuridine has been researched along with azaserine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Kochhar, DM1
Baba, M; Iishi, H; Iseki, K; Nakaizumi, A; Tatsuta, M; Uehara, H; Yano, H1
Ishihara, H; Ishiki, M; Kishida, M; Kobayashi, M; Nakamura, N; Sasaoka, T; Sato, A; Takata, M; Temaru, R; Urakaze, M; Usui, I; Wada, T; Yamazaki, K1
Bierkamp, C; Clerc, P; Dufresne, M; Fourmy, D; Lulka, H; Mathieu, A; Portolan, G; Pradayrol, L; Seva, C1

Other Studies

5 other study(ies) available for bromodeoxyuridine and azaserine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
The use of in vitro procedures in teratology.
    Teratology, 1975, Volume: 11, Issue:3

    Topics: Abnormalities, Drug-Induced; Aminopropionitrile; Aminopterin; Animals; Azaserine; Bromodeoxyuridine; Culture Media; Culture Techniques; Diazooxonorleucine; DNA; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryo, Nonmammalian; Embryology; Extremities; Female; Gestational Age; Limb Deformities, Congenital; Niacinamide; Protein Biosynthesis; Teratogens; Thalidomide; Vitamin A; Vitelline Membrane

1975
Inhibition by galanin of experimental carcinogenesis induced by azaserine in rat pancreas.
    International journal of cancer, 1998, Jan-30, Volume: 75, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Azaserine; Body Weight; Bromodeoxyuridine; Carcinogens; Galanin; Male; Norepinephrine; Organ Size; Pancreas; Pancreatic Neoplasms; Rats; Rats, Wistar

1998
Glucosamine enhances platelet-derived growth factor-induced DNA synthesis via phosphatidylinositol 3-kinase pathway in rat aortic smooth muscle cells.
    Atherosclerosis, 2001, Volume: 157, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Aorta; Azaserine; Bromodeoxyuridine; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glucosamine; Glucose; GRB2 Adaptor Protein; Isoenzymes; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phospholipase C gamma; Phosphorylation; Platelet-Derived Growth Factor; Proteins; Rats; Receptor, Platelet-Derived Growth Factor beta; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Type C Phospholipases; Tyrosine

2001
Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.
    International journal of cancer, 2005, May-20, Volume: 115, Issue:1

    Topics: Adenoma; Animals; Antimetabolites, Antineoplastic; Azaserine; Bromodeoxyuridine; Carcinogens; Carcinoma, Acinar Cell; Cell Proliferation; Coloring Agents; Homeodomain Proteins; Homozygote; Immunohistochemistry; Inflammation; Lymphocytes; Mice; Mice, Transgenic; Pancreatic Neoplasms; Phenotype; Precancerous Conditions; Receptor, Cholecystokinin B; Receptors, G-Protein-Coupled; Risk; Time Factors; Trans-Activators; Transgenes

2005